Cholangiokines: undervalued modulators in the hepatic microenvironment

The biliary epithelial cells, also known as cholangiocytes, line the intra- and extrahepatic bile ducts, forming a barrier between intra- and extra-ductal environments. Cholangiocytes are mostly known to modulate bile composition and transportation. In hepatobiliary diseases, bile duct injury leads to drastic alterations in cholangiocyte phenotypes and their release of soluble mediators, which can vary depending on the original insult and cellular states (quiescence, senescence, or proliferation). The cholangiocyte-secreted cytokines (also termed cholangiokines) drive ductular cell proliferation, portal inflammation and fibrosis, and carcinogenesis. Hence, despite the previous consensus that cholangiocytes are bystanders in liver diseases, their diverse secretome plays critical roles in modulating the intrahepatic microenvironment. This review summarizes recent insights into the cholangiokines under both physiological and pathological conditions, especially as they occur during liver injury-regeneration, inflammation, fibrosis and malignant transformation processes.

[1]  F. Tacke,et al.  Mapping the hepatic immune landscape identifies monocytic macrophages as key drivers of steatohepatitis and cholangiopathy progression , 2023, Hepatology.

[2]  Chuanyong Guo,et al.  The Gut Microbiome and Ferroptosis in MAFLD , 2022, Journal of clinical and translational hepatology.

[3]  Hanyang Liu,et al.  Cellular Senescence in Hepatocellular Carcinoma: The Passenger or the Driver? , 2022, Cells.

[4]  Lee M. Tatham,et al.  FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2 , 2022, Nature.

[5]  H. Tilg,et al.  Gut-liver axis: Pathophysiological concepts and clinical implications. , 2022, Cell metabolism.

[6]  Huanming Yang,et al.  Single-cell Stereo-seq reveals induced progenitor cells involved in axolotl brain regeneration , 2022, Science.

[7]  N. Björkström Immunobiology of the biliary tract system , 2022, Journal of hepatology.

[8]  A. Lok,et al.  Biliary NIK promotes ductular reaction and liver injury and fibrosis in mice , 2022, Nature Communications.

[9]  H. Benyamini,et al.  Combined hepatocellular-cholangiocarcinoma derives from liver progenitor cells and depends on senescence and IL6 trans-signaling. , 2022, Journal of hepatology.

[10]  Hong Liu,et al.  The gut–liver axis in sepsis: interaction mechanisms and therapeutic potential , 2022, Critical Care.

[11]  Jun Wang,et al.  Cellular Homeostasis and Repair in the Biliary Tree. , 2022, Seminars in liver disease (Print).

[12]  K. Kanetaka,et al.  Helicobacter bilis infection induces oxidative stress in and enhances the proliferation of human cholangiocytes , 2022, Helicobacter.

[13]  Yue Chen,et al.  Mechanisms of ductular reaction in non-alcoholic steatohepatitis , 2022, World journal of gastroenterology.

[14]  K. Nakao,et al.  C‐X‐C motif chemokine ligand 1 induced by Hedgehog signaling promotes mouse extrahepatic bile duct repair after acute injury , 2022, Hepatology.

[15]  F. Tacke,et al.  Location, location, location — spatial insight into hepatic macrophage populations , 2022, Nature Reviews Gastroenterology & Hepatology.

[16]  L. Ohno-Machado,et al.  Protein and miRNA profile of circulating extracellular vesicles in patients with primary sclerosing cholangitis , 2022, Scientific Reports.

[17]  N. LaRusso,et al.  Cellular senescence in the cholangiopathies: a driver of immunopathology and a novel therapeutic target , 2022, Seminars in Immunopathology.

[18]  F. Tacke,et al.  Macrophages in cholangiopathies , 2021, Current opinion in gastroenterology.

[19]  C. Huttenhower,et al.  Human gut bacteria produce TH17-modulating bile acid metabolites , 2021, bioRxiv.

[20]  S. Chakraborty,et al.  Biliary Epithelial Senescence in Liver Disease: There Will Be SASP , 2021, Frontiers in Molecular Biosciences.

[21]  Mingyue Zhu,et al.  IL-6/STAT3 Is a Promising Therapeutic Target for Hepatocellular Carcinoma , 2021, Frontiers in Oncology.

[22]  Shi‐Mei Zhuang,et al.  Identification of a TGF-β/SMAD/lnc-UTGF positive feedback loop and its role in hepatoma metastasis , 2021, Signal Transduction and Targeted Therapy.

[23]  Xiaoling Xu,et al.  Cullin3 deficiency shapes tumor microenvironment and promotes cholangiocarcinoma in liver-specific Smad4/Pten mutant mice , 2021, International journal of biological sciences.

[24]  E. Witze,et al.  Regulation of EGFR signalling by palmitoylation and its role in tumorigenesis , 2021, Open Biology.

[25]  P. Tangkijvanich,et al.  The LIN28B/TGF-β/TGFBI feedback loop promotes cell migration and tumour initiation potential in cholangiocarcinoma , 2021, Cancer Gene Therapy.

[26]  S. Macdonald,et al.  Emerging therapeutic opportunities for integrin inhibitors , 2021, Nature reviews. Drug discovery.

[27]  R. Bataller,et al.  Ductular reaction promotes intrahepatic angiogenesis through Slit2–Roundabout 1 signaling , 2021, Hepatology.

[28]  S. Glaser,et al.  Feedback Signaling between Cholangiopathies, Ductular Reaction, and Non-Alcoholic Fatty Liver Disease , 2021, Cells.

[29]  Jia Fan,et al.  Cystathionine β-synthase mediated PRRX2/IL-6/STAT3 inactivation suppresses Tregs infiltration and induces apoptosis to inhibit HCC carcinogenesis , 2021, Journal for ImmunoTherapy of Cancer.

[30]  E. Harris,et al.  Pathophysiological Communication between Hepatocytes and Non-Parenchymal Cells in Liver Injury from NAFLD to Liver Fibrosis. , 2021, Advanced drug delivery reviews.

[31]  Qi Zhang,et al.  Topological analysis of hepatocellular carcinoma tumour microenvironment based on imaging mass cytometry reveals cellular neighbourhood regulated reversely by macrophages with different ontogeny , 2021, Gut.

[32]  F. Tacke,et al.  Liver Injury and the Macrophage Issue: Molecular and Mechanistic Facts and Their Clinical Relevance , 2021, International journal of molecular sciences.

[33]  F. Tacke,et al.  The Role of Microbiota in Primary Sclerosing Cholangitis and Related Biliary Malignancies , 2021, International journal of molecular sciences.

[34]  R. Sandford,et al.  The Serum Proteome and Ursodeoxycholic Acid Response in Primary Biliary Cholangitis , 2021, Hepatology.

[35]  G. Minuk,et al.  Fibroblast Growth Factor 19 Induced Changes in Non-malignant Cholangiocytes , 2021, Journal of clinical and translational hepatology.

[36]  S. Forbes,et al.  Liver regeneration and inflammation: from fundamental science to clinical applications , 2021, Nature Reviews Molecular Cell Biology.

[37]  Yasunori Sato,et al.  Interferon-induced protein with tetratricopeptide repeats 3 may be a key factor in primary biliary cholangitis , 2021, Scientific Reports.

[38]  Sooah Kim,et al.  Cholangiopathy After Severe COVID-19: Clinical Features and Prognostic Implications , 2021, The American journal of gastroenterology.

[39]  M. Altfeld,et al.  Single-cell atlas of hepatic T cells reveals expansion of liver-resident naive-like CD4+ T cells in primary sclerosing cholangitis , 2021, Journal of hepatology.

[40]  K. Schuebel,et al.  Bile acid-activated macrophages promote biliary epithelial cell proliferation through integrin αvβ6 upregulation following liver injury. , 2021, The Journal of clinical investigation.

[41]  K. Tsuneyama,et al.  Ursodeoxycholic acid impairs liver‐infiltrating T‐cell chemotaxis through IFN‐γ and CX3CL1 production in primary biliary cholangitis , 2021, European journal of immunology.

[42]  J. Boyer,et al.  Bile formation and Secretion: An update. , 2021, Journal of hepatology.

[43]  Yi Zhao,et al.  Imbalance of TGF-β1/BMP-7 Pathways Induced by M2-polarized Macrophages Promotes Hepatocellular Carcinoma Aggressiveness. , 2021, Molecular therapy : the journal of the American Society of Gene Therapy.

[44]  R. Fiorotto,et al.  New insights on the role of vascular endothelial growth factor in biliary pathophysiology , 2021, JHEP reports : innovation in hepatology.

[45]  Aurélie Beaufrère,et al.  Combined hepatocellular-cholangiocarcinoma: An update. , 2021, Journal of hepatology.

[46]  N. LaRusso,et al.  Genetic or pharmacological reduction of cholangiocyte senescence improves inflammation and fibrosis in the Mdr2-/- mouse , 2021, JHEP reports : innovation in hepatology.

[47]  J. Crawford,et al.  Post–COVID-19 Cholangiopathy: A Novel Entity , 2021, The American journal of gastroenterology.

[48]  A. Mullen,et al.  Our emerging understanding of the roles of long non-coding RNAs in normal liver function, disease, and malignancy , 2020, JHEP reports : innovation in hepatology.

[49]  Bo Li,et al.  A novel model of injured liver ductal organoids to investigate cholangiocyte apoptosis with relevance to biliary atresia , 2020, Pediatric Surgery International.

[50]  V. Shah,et al.  Epigenomic Evaluation of Cholangiocyte TGFβ Signaling Identifies a Selective Role for Histone 3 Lysine 9 Acetylation in Biliary Fibrosis. , 2020, Gastroenterology.

[51]  F. Tacke,et al.  Deciphering the Immune Microenvironment on A Single Archival Formalin-Fixed Paraffin-Embedded Tissue Section by An Immediately Implementable Multiplex Fluorescence Immunostaining Protocol , 2020, Cancers.

[52]  G. Michalopoulos,et al.  Liver regeneration: biological and pathological mechanisms and implications , 2020, Nature Reviews Gastroenterology & Hepatology.

[53]  P. Ohashi,et al.  The Roles of CD8+ T Cell Subsets in Antitumor Immunity. , 2020, Trends in cell biology.

[54]  N. LaRusso,et al.  Senescent cholangiocytes release extracellular vesicles that alter target cell phenotype via the epidermal growth factor receptor , 2020, Liver international : official journal of the International Association for the Study of the Liver.

[55]  Yuan Zhang,et al.  Single cell transcriptomic architecture and intercellular crosstalk of human intrahepatic cholangiocarcinoma. , 2020, Journal of hepatology.

[56]  A. Benedetti,et al.  Gut–Liver Axis and Inflammasome Activation in Cholangiocyte Pathophysiology , 2020, Cells.

[57]  A. Franke,et al.  Monocytes as Potential Mediators of Pathogen‐Induced T‐Helper 17 Differentiation in Patients With Primary Sclerosing Cholangitis (PSC) , 2020, Hepatology.

[58]  W. Zhou,et al.  TMPRSS4 Drives Angiogenesis in Hepatocellular Carcinoma by Promoting HB‐EGF Expression and Proteolytic Cleavage , 2019, Hepatology.

[59]  G. Gores,et al.  The Spectrum of Reactive Cholangiocytes in Primary Sclerosing Cholangitis , 2019, Hepatology.

[60]  Runping Liu,et al.  Cholangiocyte‐Derived Exosomal Long Noncoding RNA H19 Promotes Hepatic Stellate Cell Activation and Cholestatic Liver Fibrosis , 2019, Hepatology.

[61]  J. Gingold,et al.  Immunomodulatory TGF-β Signaling in Hepatocellular Carcinoma. , 2019, Trends in molecular medicine.

[62]  L. Fabris,et al.  Secretin/secretin receptor signaling mediates biliary damage and liver fibrosis in early‐stage primary biliary cholangitis , 2019, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[63]  V. Mazzi Mig chemokine in primary biliary cirrhosis. , 2019, La Clinica terapeutica.

[64]  L. Fabris,et al.  The tumour microenvironment and immune milieu of cholangiocarcinoma , 2019, Liver international : official journal of the International Association for the Study of the Liver.

[65]  S. Cockell,et al.  High‐throughput sequencing identifies aetiology‐dependent differences in ductular reaction in human chronic liver disease , 2019, The Journal of pathology.

[66]  F. Tacke,et al.  Liver Macrophages: Old Dogmas and New Insights , 2019, Hepatology communications.

[67]  Jacquelyn O. Russell,et al.  Hepatocyte‐Specific β‐catenin Deletion During Severe Liver Injury Provokes Cholangiocytes to Differentiate into Hepatocytes , 2019, The FASEB Journal.

[68]  G. Gores,et al.  Intrahepatic Cholangiocarcinoma: Continuing Challenges and Translational Advances , 2019, Hepatology.

[69]  S. Forbes,et al.  Hepatocyte‐Specific β‐Catenin Deletion During Severe Liver Injury Provokes Cholangiocytes to Differentiate Into Hepatocytes , 2019, Hepatology.

[70]  S. Glaser,et al.  Ductular Reaction in Liver Diseases: Pathological Mechanisms and Translational Significances , 2018, Hepatology.

[71]  A. Tanaka,et al.  Pathogen infections and primary biliary cholangitis , 2018, Clinical and experimental immunology.

[72]  G. Gores,et al.  Cholangiocyte pathobiology , 2019, Nature Reviews Gastroenterology & Hepatology.

[73]  Gary D Bader,et al.  Single cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations , 2018, Nature Communications.

[74]  A. Benedetti,et al.  Inflammation and the Gut-Liver Axis in the Pathophysiology of Cholangiopathies , 2018, International journal of molecular sciences.

[75]  P. Tam,et al.  Cholangiopathies – Towards a molecular understanding , 2018, EBioMedicine.

[76]  H. Larjava,et al.  Integrin αvβ6: Structure, function and role in health and disease. , 2018, The international journal of biochemistry & cell biology.

[77]  M. Demaria,et al.  Hallmarks of Cellular Senescence. , 2018, Trends in cell biology.

[78]  S. Glaser,et al.  Biliary epithelium: A neuroendocrine compartment in cholestatic liver disease. , 2018, Clinics and research in hepatology and gastroenterology.

[79]  E. O'Duibhir,et al.  Paracrine cellular senescence exacerbates biliary injury and impairs regeneration , 2018, Nature Communications.

[80]  T. Chieochansin,et al.  Inhibition of IL-10 and TGF-β receptors on dendritic cells enhances activation of effector T-cells to kill cholangiocarcinoma cells , 2018, Human vaccines & immunotherapeutics.

[81]  J. Pawlotsky,et al.  Interleukins‐17 and 27 promote liver regeneration by sequentially inducing progenitor cell expansion and differentiation , 2018, Hepatology communications.

[82]  G. Gores,et al.  Targeting senescent cholangiocytes and activated fibroblasts with B‐cell lymphoma‐extra large inhibitors ameliorates fibrosis in multidrug resistance 2 gene knockout (Mdr2−/−) mice , 2018, Hepatology.

[83]  Soyoung Lee,et al.  Senescence-associated reprogramming promotes cancer stemness , 2017, Nature.

[84]  D. Gotthardt,et al.  Pathological features of primary sclerosing cholangitis identified by bile proteomic analysis. , 2017, Biochimica et biophysica acta. Molecular basis of disease.

[85]  G. Kullak-Ublick,et al.  Drug-induced bile duct injury. , 2017, Biochimica et biophysica acta. Molecular basis of disease.

[86]  R. Fiorotto,et al.  Pathophysiologic implications of innate immunity and autoinflammation in the biliary epithelium. , 2017, Biochimica et biophysica acta. Molecular basis of disease.

[87]  T. Luong,et al.  Pathogenesis of biliary fibrosis. , 2017, Biochimica et biophysica acta. Molecular basis of disease.

[88]  M. Marzioni,et al.  Role of inflammation and proinflammatory cytokines in cholangiocyte pathophysiology. , 2017, Biochimica et biophysica acta. Molecular basis of disease.

[89]  R. Urtasun,et al.  Bile acids, FGF15/19 and liver regeneration: From mechanisms to clinical applications. , 2017, Biochimica et biophysica acta. Molecular basis of disease.

[90]  R. Fiorotto,et al.  The deleterious interplay between tumor epithelia and stroma in cholangiocarcinoma. , 2017, Biochimica et biophysica acta. Molecular basis of disease.

[91]  M. Croft,et al.  TNF activity and T cells. , 2018, Cytokine.

[92]  S. Glaser,et al.  Regulation of Cellular Senescence by miR-34a in Alcoholic Liver Injury. , 2017, The American journal of pathology.

[93]  P. Xue,et al.  Role of AP-2α and MAPK7 in the regulation of autocrine TGF-β/miR-200b signals to maintain epithelial-mesenchymal transition in cholangiocarcinoma , 2017, Journal of Hematology & Oncology.

[94]  C. Spirlí,et al.  Emerging concepts in biliary repair and fibrosis. , 2017, American journal of physiology. Gastrointestinal and liver physiology.

[95]  T. Tordjmann,et al.  Bile acids and their receptors during liver regeneration: "Dangerous protectors". , 2017, Molecular aspects of medicine.

[96]  Darjus F. Tschaharganeh,et al.  Kupffer Cell-Derived Tnf Triggers Cholangiocellular Tumorigenesis through JNK due to Chronic Mitochondrial Dysfunction and ROS. , 2017, Cancer cell.

[97]  F. Lund-Johansen,et al.  Novel serum and bile protein markers predict primary sclerosing cholangitis disease severity and prognosis. , 2017, Journal of hepatology.

[98]  Wei-Yu Lu,et al.  Cholangiocytes act as Facultative Liver Stem Cells during Impaired Hepatocyte Regeneration , 2017, Nature.

[99]  Wei-Chung Cheng,et al.  Corylin protects LPS-induced sepsis and attenuates LPS-induced inflammatory response , 2017, Scientific Reports.

[100]  F. Tacke,et al.  Liver macrophages in tissue homeostasis and disease , 2017, Nature Reviews Immunology.

[101]  T. Karlsen,et al.  Nlrp3 Activation Induces Il-18 Synthesis and Affects the Epithelial Barrier Function in Reactive Cholangiocytes. , 2017, The American journal of pathology.

[102]  R. Venkataramanan,et al.  Drug Metabolism in the Liver. , 2017, Clinics in liver disease.

[103]  T. D. de Assunção,et al.  Regenerative Medicine and the Biliary Tree , 2017, Seminars in Liver Disease.

[104]  F. Tacke,et al.  Liver — guardian, modifier and target of sepsis , 2017, Nature Reviews Gastroenterology &Hepatology.

[105]  P. Dijke,et al.  Immunoregulation by members of the TGFβ superfamily , 2016, Nature Reviews Immunology.

[106]  X. Wang,et al.  Distinct Functions of Senescence-Associated Immune Responses in Liver Tumor Surveillance and Tumor Progression. , 2016, Cancer cell.

[107]  H. Choi,et al.  Biology of Cholangiocytes: From Bench to Bedside , 2016, Gut and liver.

[108]  T. Karlsen,et al.  Elevated interleukin‐8 in bile of patients with primary sclerosing cholangitis , 2016, Liver international : official journal of the International Association for the Study of the Liver.

[109]  A. Franchitto,et al.  The secretin/secretin receptor axis modulates liver fibrosis through changes in transforming growth factor‐β1 biliary secretion in mice , 2016, Hepatology.

[110]  Q. Xia,et al.  Role of Osteopontin in Liver Diseases , 2016, International journal of biological sciences.

[111]  G. Carpino,et al.  The hepatic, biliary, and pancreatic network of stem/progenitor cell niches in humans: A new reference frame for disease and regeneration , 2016, Hepatology.

[112]  Stefan Rose-John,et al.  IL-6 pathway in the liver: From physiopathology to therapy. , 2016, Journal of hepatology.

[113]  D. Bobbala,et al.  Negative regulation of the hepatic fibrogenic response by suppressor of cytokine signaling 1. , 2016, Cytokine.

[114]  B. Chassaing,et al.  Hepatocyte Toll-Like Receptor 5 Promotes Bacterial Clearance and Protects Mice Against High-Fat Diet–Induced Liver Disease , 2016, Cellular and molecular gastroenterology and hepatology.

[115]  R. Takata,et al.  Impact of serum Wisteria floribunda agglutinin positive Mac‐2‐binding protein and serum interferon‐γ‐inducible protein‐10 in primary biliary cirrhosis , 2016, Hepatology research : the official journal of the Japan Society of Hepatology.

[116]  P. Klenerman,et al.  Biliary epithelium and liver B cells exposed to bacteria activate intrahepatic MAIT cells through MR1 , 2016, Journal of hepatology.

[117]  D. Schuppan,et al.  Macrophage recruitment by fibrocystin‐defective biliary epithelial cells promotes portal fibrosis in congenital hepatic fibrosis , 2016, Hepatology.

[118]  Xiaochen Bo,et al.  Influence of the Biliary System on Biliary Bacteria Revealed by Bacterial Communities of the Human Biliary and Upper Digestive Tracts , 2016, PloS one.

[119]  Frank Tacke,et al.  Immunology in the liver — from homeostasis to disease , 2016, Nature Reviews Gastroenterology &Hepatology.

[120]  D. Schuppan,et al.  Integrin αvβ6 critically regulates hepatic progenitor cell function and promotes ductular reaction, fibrosis, and tumorigenesis , 2016, Hepatology.

[121]  J. Zhu,et al.  In Sickness and in Health: The Relationships Between Bacteria and Bile in the Human Gut. , 2016, Advances in applied microbiology.

[122]  T. Karlsen,et al.  The biliary epithelium presents antigens to and activates natural killer T cells , 2015, Hepatology.

[123]  D. Häussinger,et al.  TGR5 is essential for bile acid-dependent cholangiocyte proliferation in vivo and in vitro , 2015, Gut.

[124]  E. Scott,et al.  Connective tissue growth factor and integrin αvβ6: A new pair of regulators critical for ductular reaction and biliary fibrosis in mice , 2015, Hepatology.

[125]  Hongxin Ma,et al.  Tim-3 fosters HCC development by enhancing TGF-β-mediated alternative activation of macrophages , 2015, Gut.

[126]  K. Lindor,et al.  Primary biliary cirrhosis , 2003, The Lancet.

[127]  N. LaRusso,et al.  The Cholangiopathies. , 2015, Mayo Clinic proceedings.

[128]  John J. Cole,et al.  HIRA orchestrates a dynamic chromatin landscape in senescence and is required for suppression of neoplasia , 2014, Genes & development.

[129]  Kosei Maemura,et al.  Molecular mechanism of cholangiocarcinoma carcinogenesis , 2014, Journal of hepato-biliary-pancreatic sciences.

[130]  R. Bataller,et al.  The biliary epithelium gives rise to liver progenitor cells , 2014, Hepatology.

[131]  H. Saya,et al.  Tumor necrosis factor‐α modulates epithelial mesenchymal transition mediators ZEB2 and S100A4 to promote cholangiocarcinoma progression , 2014, Journal of hepato-biliary-pancreatic sciences.

[132]  V. Paradis,et al.  EGF/EGFR axis contributes to the progression of cholangiocarcinoma through the induction of an epithelial-mesenchymal transition. , 2014, Journal of hepatology.

[133]  N. LaRusso,et al.  Characterization of cultured cholangiocytes isolated from livers of patients with primary sclerosing cholangitis , 2014, Laboratory Investigation.

[134]  A. Franchitto,et al.  Secretin stimulates biliary cell proliferation by regulating expression of microRNA 125b and microRNA let7a in mice. , 2014, Gastroenterology.

[135]  N. LaRusso,et al.  AUTOIMMUNE, CHOLESTATIC AND BILIARY DISEASE Cholangiocyte Senescence by Way of N-Ras Activation Is a Characteristic of Primary Sclerosing Cholangitis , 2014 .

[136]  Anthony D. Schmitt,et al.  Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma , 2014, Hepatology.

[137]  C. Desbois-Mouthon,et al.  Hepatic myofibroblasts promote the progression of human cholangiocarcinoma through activation of epidermal growth factor receptor , 2013, Hepatology.

[138]  A. Franchitto,et al.  Recent advances in the morphological and functional heterogeneity of the biliary epithelium , 2013, Experimental biology and medicine.

[139]  N. LaRusso,et al.  The dynamic biliary epithelia: molecules, pathways, and disease. , 2013, Journal of hepatology.

[140]  S. Morini,et al.  Identification of fibroblast growth factor 15 as a novel mediator of liver regeneration and its application in the prevention of post-resection liver failure in mice , 2013, Gut.

[141]  Y. Nakanuma,et al.  Participation of natural killer cells in the pathogenesis of bile duct lesions in biliary atresia , 2012, Journal of Clinical Pathology.

[142]  J. Dranoff,et al.  Advances in cholangiocyte immunobiology. , 2012, American journal of physiology. Gastrointestinal and liver physiology.

[143]  X. Yao,et al.  Clinicopathological and prognostic significance of epithelial mesenchymal transition-related protein expression in intrahepatic cholangiocarcinoma , 2012, OncoTargets and therapy.

[144]  Hiroshi Kimura,et al.  Independence of repressive histone marks and chromatin compaction during senescent heterochromatic layer formation. , 2012, Molecular cell.

[145]  H. Koga,et al.  Vandetanib, an Inhibitor of VEGF Receptor-2 and EGF Receptor, Suppresses Tumor Development and Improves Prognosis of Liver Cancer in Mice , 2012, Clinical Cancer Research.

[146]  W. Haigh,et al.  Liver fluke-induced hepatic oxysterols stimulate DNA damage and apoptosis in cultured human cholangiocytes. , 2012, Mutation research.

[147]  D. Gouma,et al.  The human gallbladder secretes fibroblast growth factor 19 into bile: Towards defining the role of fibroblast growth factor 19 in the enterobiliary tract , 2012, Hepatology.

[148]  T. Berg,et al.  Enhanced innate immune responsiveness and intolerance to intestinal endotoxins in human biliary epithelial cells contributes to chronic cholangitis , 2011, Liver international : official journal of the International Association for the Study of the Liver.

[149]  A. Gouw,et al.  Ductular reactions in human liver: Diversity at the interface , 2011, Hepatology.

[150]  P. Lescuyer,et al.  A step further in the analysis of human bile proteome. , 2011, Journal of proteome research.

[151]  Maylee Hsu,et al.  Significance of periductal Langerhans cells and biliary epithelial cell‐derived macrophage inflammatory protein‐3α in the pathogenesis of primary biliary cirrhosis , 2011, Liver international : official journal of the International Association for the Study of the Liver.

[152]  N. LaRusso,et al.  Opisthorchis viverrini excretory/secretory products induce toll-like receptor 4 upregulation and production of interleukin 6 and 8 in cholangiocyte. , 2010, Parasitology international.

[153]  Yasunori Sato,et al.  Modulation of the microenvironment by senescent biliary epithelial cells may be involved in the pathogenesis of primary biliary cirrhosis. , 2010, Journal of hepatology.

[154]  R. Mancinelli,et al.  Knockout of secretin receptor reduces large cholangiocyte hyperplasia in mice with extrahepatic cholestasis induced by bile duct ligation , 2010, Hepatology.

[155]  A. Kimura,et al.  IL‐6: Regulator of Treg/Th17 balance , 2010, European journal of immunology.

[156]  R. Mancinelli,et al.  Gastrointestinal , Hepatobiliary and Pancreatic Pathology After Damage of Large Bile Ducts by Gamma-Aminobutyric Acid , Small Ducts Replenish the Biliary Tree by Amplification of Calcium-Dependent Signaling and de Novo Acquisition of Large Cholangiocyte Phenotypes , 2010 .

[157]  Guoku Hu,et al.  miR-221 suppresses ICAM-1 translation and regulates interferon-gamma-induced ICAM-1 expression in human cholangiocytes. , 2010, American journal of physiology. Gastrointestinal and liver physiology.

[158]  K. Isse,et al.  Periductal interleukin‐17 production in association with biliary innate immunity contributes to the pathogenesis of cholangiopathy in primary biliary cirrhosis , 2009, Clinical and experimental immunology.

[159]  I. McKillop,et al.  Ethanol-TGFalpha-MEK signaling promotes growth of human hepatocellular carcinoma. , 2009, The Journal of surgical research.

[160]  D. Gouma,et al.  High expression of the bile salt‐homeostatic hormone fibroblast growth factor 19 in the liver of patients with extrahepatic cholestasis , 2009, Hepatology.

[161]  R. Mancinelli,et al.  Taurocholate Feeding to Bile Duct Ligated Rats Prevents Caffeic Acid-Induced Bile Duct Damage by Changes in Cholangiocyte VEGF Expression , 2009, Experimental biology and medicine.

[162]  D. Wendum,et al.  Bile salts control the antimicrobial peptide cathelicidin through nuclear receptors in the human biliary epithelium. , 2009, Gastroenterology.

[163]  A. Franchitto,et al.  Estrogens stimulate the proliferation of human cholangiocarcinoma by inducing the expression and secretion of vascular endothelial growth factor. , 2009, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[164]  G. Soukup,et al.  MicroRNA-513 Regulates B7-H1 Translation and Is Involved in IFN-γ-Induced B7-H1 Expression in Cholangiocytes12 , 2009, The Journal of Immunology.

[165]  S. Ramaiah,et al.  Review Pathophysiological Role of Osteopontin in Hepatic Inflammation, Toxicity, and Cancer , 2007 .

[166]  H. Friess,et al.  Integrin alphavbeta6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapies. , 2008, Journal of hepatology.

[167]  L. Boon,et al.  Coculture of human liver macrophages and cholangiocytes leads to CD40‐dependent apoptosis and cytokine secretion , 2007, Hepatology.

[168]  S. Glaser,et al.  Cholangiocyte injury and ductopenic syndromes. , 2007, Seminars in liver disease.

[169]  K. Isse,et al.  IL‐8 expression by biliary epithelial cells is associated with neutrophilic infiltration and reactive bile ductules , 2007, Liver international : official journal of the International Association for the Study of the Liver.

[170]  G. Michalopoulos,et al.  Liver Regeneration , 1997, Journal of cellular physiology.

[171]  Dimitris Kletsas,et al.  Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints , 2006, Nature.

[172]  R. Wells Faculty Opinions recommendation of Secretion of MCP-1/CCL2 by bile duct epithelia induces myofibroblastic transdifferentiation of portal fibroblasts. , 2006 .

[173]  F. Balkwill TNF-α in promotion and progression of cancer , 2006, Cancer and Metastasis Reviews.

[174]  A. Franchitto,et al.  Estrogens and insulin-like growth factor 1 modulate neoplastic cell growth in human cholangiocarcinoma. , 2006, The American journal of pathology.

[175]  K. Migita,et al.  Human intrahepatic biliary epithelial cells function in innate immunity by producing IL‐6 and IL‐8 via the TLR4‐NF‐κB and ‐MAPK signaling pathways , 2006, Liver international : official journal of the International Association for the Study of the Liver.

[176]  J. Dranoff,et al.  Secretion of MCP-1/CCL2 by bile duct epithelia induces myofibroblastic transdifferentiation of portal fibroblasts. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[177]  Hajime Isomoto,et al.  Interleukin 6 upregulates myeloid cell leukemia‐1 expression through a STAT3 pathway in cholangiocarcinoma cells , 2005, Hepatology.

[178]  A. Franchitto,et al.  The intrahepatic biliary epithelium is a target of the growth hormone/insulin-like growth factor 1 axis. , 2005, Journal of hepatology.

[179]  K. Isse,et al.  Fractalkine and CX3CR1 are involved in the recruitment of intraepithelial lymphocytes of intrahepatic bile ducts , 2005, Hepatology.

[180]  T. Mcclanahan,et al.  IL-23 drives a pathogenic T cell population that induces autoimmune inflammation , 2005, The Journal of experimental medicine.

[181]  J. Costerton,et al.  Defense system in the biliary tract against bacterial infection , 1992, Digestive Diseases and Sciences.

[182]  L. Trümper From bench to bedside , 2005, Medizinische Klinik.

[183]  T. Oda,et al.  Inhibition of Jagged-mediated Notch signaling disrupts zebrafish biliary development and generates multi-organ defects compatible with an Alagille syndrome phenocopy , 2004, Development.

[184]  S. Glaser,et al.  Nerve growth factor modulates the proliferative capacity of the intrahepatic biliary epithelium in experimental cholestasis. , 2004, Gastroenterology.

[185]  T. Hirayama,et al.  Peptide antibiotic human beta‐defensin‐1 and ‐2 contribute to antimicrobial defense of the intrahepatic biliary tree , 2004, Hepatology.

[186]  R. Taub Liver regeneration: from myth to mechanism , 2004, Nature Reviews Molecular Cell Biology.

[187]  D. Seo,et al.  Oxysterols from human bile induce apoptosis of canine gallbladder epithelial cells in monolayer culture. , 2004, American journal of physiology. Gastrointestinal and liver physiology.

[188]  V. Luketic,et al.  A Review of the Physiological and Immunological Functions of Biliary Epithelial Cells: Targets for Primary Biliary Cirrhosis, Primary Sclerosing Cholangitis and Drug-induced Ductopenias , 2004, Clinical & developmental immunology.

[189]  G. Gores,et al.  Oxysterols induce cyclooxygenase‐2 expression in cholangiocytes: Implications for biliary tract carcinogenesis , 2004, Hepatology.

[190]  N. LaRusso,et al.  Cytokine-stimulated nitric oxide production inhibits adenylyl cyclase and cAMP-dependent secretion in cholangiocytes. , 2003, Gastroenterology.

[191]  E. Levy,et al.  Effects of bile acids on biliary epithelial cells: proliferation, cytotoxicity, and cytokine secretion. , 2003, Life sciences.

[192]  R. Hultcrantz,et al.  The Myofibroblastic Conversion of Peribiliary Fibrogenic Cells Distinct from Hepatic Stellate Cells Is Stimulated by Platelet-Derived Growth Factor During Liver Fibrogenesis , 2003, Laboratory Investigation.

[193]  T. Kawaguchi,et al.  Tumor necrosis factor-alpha and interferon-gamma directly impair epithelial barrier function in cultured mouse cholangiocytes. , 2003, Liver international : official journal of the International Association for the Study of the Liver.

[194]  D. Adams,et al.  The role of cholangiocytes in the development of chronic inflammatory liver disease. , 2002, Frontiers in bioscience : a journal and virtual library.

[195]  D. Black,et al.  Regulation of triacylglycerol and phospholipid trafficking by fatty acids in newborn swine enterocytes. , 2002, American journal of physiology. Gastrointestinal and liver physiology.

[196]  S. Glaser,et al.  Functional heterogeneity of cholangiocytes. , 2002, Seminars in liver disease.

[197]  M. Ulaganathan,et al.  Biliary epithelial trefoil peptide expression is increased in biliary diseases , 2002, Histopathology.

[198]  D. Schuppan,et al.  Proliferating bile duct epithelial cells are a major source of connective tissue growth factor in rat biliary fibrosis. , 2001, The American journal of pathology.

[199]  T. Patel,et al.  Involvement of p38 mitogen‐activated protein kinase signaling in transformed growth of a cholangiocarcinoma cell line , 2001, Hepatology.

[200]  C. Sempoux,et al.  Drug and toxin‐induced bile duct disorders , 2000, Journal of gastroenterology and hepatology.

[201]  J. Lunz,et al.  Growth control of human biliary epithelial cells by interleukin 6, hepatocyte growth factor, transforming growth factor β1, and activin a: Comparison of a cholangiocarcinoma cell line with primary cultures of non‐neoplastic biliary epithelial cells , 2000, Hepatology.

[202]  U. Beuers,et al.  Hepatobiliary transport. , 2000, Journal of hepatology.

[203]  P. Beaune,et al.  Phase I and Phase II drug‐metabolizing enzymes are expressed and heterogeneously distributed in the biliary epithelium , 1999, Hepatology.

[204]  H. Herbst,et al.  Expression of platelet-derived growth factor in newly formed cholangiocytes during experimental biliary fibrosis in rats. , 1999, Journal of hepatology.

[205]  N. Fausto,et al.  Tumor necrosis factor induces DNA replication in hepatic cells through nuclear factor kappaB activation. , 1999, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[206]  G. Michalopoulos,et al.  Interleukin‐6, hepatocyte growth factor, and their receptors in biliary epithelial cells during a type i ductular reaction in mice: Interactions between the periductal inflammatory and stromal cells and the biliary epithelium , 1998, Hepatology.

[207]  S. Lowe,et al.  Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. , 1998, Genes & development.

[208]  K. Tanikawa,et al.  Abnormal accumulation of endotoxin in biliary epithelial cells in primary biliary cirrhosis and primary sclerosing cholangitis. , 1998, Journal of hepatology.

[209]  James S Goydos,et al.  Marked elevation of serum interleukin-6 in patients with cholangiocarcinoma: validation of utility as a clinical marker. , 1998, Annals of surgery.

[210]  S. Milani,et al.  Increased expression of monocyte chemotactic protein-1 during active hepatic fibrogenesis: correlation with monocyte infiltration. , 1998, The American journal of pathology.

[211]  Y. Nakanuma,et al.  Increased expression of interleukin-6 and tumor necrosis factor-alpha in pathologic biliary epithelial cells: in situ and culture study. , 1998, Laboratory investigation; a journal of technical methods and pathology.

[212]  N. LaRusso,et al.  The pathobiology of biliary epithelia , 2002, Hepatology.

[213]  T. Schall,et al.  Identification and Molecular Characterization of Fractalkine Receptor CX3CR1, which Mediates Both Leukocyte Migration and Adhesion , 1997, Cell.

[214]  S. Glaser,et al.  gamma-Interferon inhibits secretin-induced choleresis and cholangiocyte proliferation in a murine model of cirrhosis. , 1997, Journal of hepatology.

[215]  D. Adams,et al.  Promotion of leukocyte transendothelial cell migration by chemokines derived from human biliary epithelial cells in vitro. , 1997, Proceedings of the Association of American Physicians.

[216]  D. Adams,et al.  Inflammatory cytokines stimulate human biliary epithelial cells to express interleukin-8 and monocyte chemotactic protein-1. , 1997, Biochemical Society transactions.

[217]  L. Pannarale,et al.  Hepatic microcirculation and peribiliary plexus in experimental biliary cirrhosis: a morphological study. , 1996, Gastroenterology.

[218]  M. Harada,et al.  Functional differences between hepatocytes and biliary epithelial cells in handling polymeric immunoglobulin A2 in humans, rats, and guinea pigs , 1996, Hepatology.

[219]  N. LaRusso,et al.  Morphological, molecular, and functional heterogeneity of cholangiocytes from normal rat liver. , 1996, Gastroenterology.

[220]  G. Michalopoulos,et al.  Human biliary epithelial cells secrete and respond to cytokines and hepatocyte growth factors in vitro: Interleukin‐6, hepatocyte growth factor and epidermal growth factor promote DNA synthesis in vitro , 1994, Hepatology.

[221]  N. LaRusso,et al.  Upregulation of secretin receptor gene expression in rat cholangiocytes after bile duct ligation. , 1994, The American journal of physiology.

[222]  K. Saito,et al.  Lactoferrin and lysozyme in the intrahepatic bile duct of normal livers and hepatolithiasis. An immunohistochemical study. , 1992, Journal of hepatology.

[223]  H. Stein,et al.  Transforming growth factors beta 1 and beta 2 are differentially expressed in fibrotic liver disease. , 1991, The American journal of pathology.

[224]  D. Kemp Inappropriate diagnosis of necrotizing arachnidism: Watch out Miss Muffet — but don't get paranoid , 1990, The Medical journal of Australia.

[225]  W. Brown,et al.  The role of the liver in translocation of IgA into the gastrointestinal tract. , 1989, Immunological investigations.

[226]  L. Sarkozi,et al.  Biliary physiology in rats with bile ductular cell hyperplasia. Evidence for a secretory function of proliferated bile ductules. , 1988, The Journal of clinical investigation.

[227]  K. Johnson An Update. , 1984, Journal of food protection.

[228]  R. Elferink Cholestasis , 2003, The Western journal of medicine.

[229]  L. Hayflick,et al.  The serial cultivation of human diploid cell strains. , 1961, Experimental cell research.